Immix Biopharma Inc Strategic Asset Allocation Index
Immix Biopharma Inc strategic asset allocation index. Immix Biopharma Inc (IMMX) has a Strategic Asset Allocation Index of 0.9% as of June 2026. Strategic assets (PP&E of $- plus long-term investments of $2.05 Million) total $2.05 Million, measured against net assets of $228.92 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is Immix Biopharma Inc's balance sheet to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Immix Biopharma Inc (2021–2022)
Strategic asset allocation index of Immix Biopharma Inc from 2021 to 2022. This chart shows how Immix Biopharma Inc's Strategic Asset Allocation Index has evolved across 2 annual periods from 2021 to 2022. As of June 2026, the index stands at 0.9%, representing strategic assets of $2.05 Million against net assets of $228.92 Million USD. Check Immix Biopharma Inc (IMMX) tangible net worth to evaluate the tangible quality of the company's equity base.
Immix Biopharma Inc Strategic Asset Allocation Index by Year (2021–2022)
Immix Biopharma Inc strategic asset allocation index by year from 2021 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Immix Biopharma Inc from 2021 to 2022, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Immix Biopharma Inc stock valuation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 0.0% | $3.56K | $3.56K | $- | $13.16 Million | ▼ 0.0 pp |
| 2021 | 0.0% | $5.70K | $5.70K | $- | $17.99 Million | — |